Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-093231
Filing Date
2024-08-27
Accepted
2024-08-27 13:06:37
Documents
1
Period of Report
2024-08-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2422792-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2422792-1_4seq1.xml 4 3117
  Complete submission text file 0001104659-24-093231.txt   4593
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EYENOVIA, INC. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017
Business Address
Rowe Michael M (Reporting) CIK: 0001744774 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 241246397